Longboard Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Longboard Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2023.
  • Longboard Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $286M, a 1241% increase year-over-year.
  • Longboard Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $30.2M.
  • Longboard Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$444K, a 101% decline from 2021.
  • Longboard Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $76.5M, a 30.1% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $30.2M +$30.6M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$444K -$76.9M -101% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $76.5M +$17.7M +30.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $58.8M Jan 4, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.